Part,  Chapter, Paragraph

 1   II,     5.  4.  1|        renal replacement therapy: dialysis or transplantation);~Impotence:
 2   II,     5.  4.  2|    Registries~Annual incidence of dialysis and/or transplantation (
 3   II,     5.  4.  2|  Registries~Prevalence (stock) of dialysis/transplantation (renal replacement
 4   II,     5.  4.  2|          number of new cases with dialysis and/or transplantation (
 5   II,     5.  4.  2|       year.~Prevalence (stock) of dialysis/transplantation per 100.
 6   II,     5.  4.  2|          number of all cases with dialysis/transplantation per 100,
 7   II,     5.  4.  3|        age.~Prevalence (stock) of dialysis/transplantation per 100.
 8   II,     5.  4.  4|       different for what concerns dialysis, for which patients are
 9   II,     5.  4.  4|   Scotland more than 30 times the dialysis/transplant incidence of
10   II,     5.  4.  4|    variation in the prevalence of dialysis/transplant among countries
11   II,     5.  4.  4|          high variations found in dialysis. Mortality rates are extremely
12   II,     5.  7.Acr|          Survey III~PD~Peritoneal Dialysis~PMARP~Per Million of the
13   II,     5.  7.  1|           the disease stage where dialysis and transplantation are
14   II,     5.  7.  1|       Europe is spent on treating dialysis patients. In 2001, it was
15   II,     5.  7.  1|         lower than those spent on dialysis patients (U.S. Renal Data
16   II,     5.  7.  1|          5~Kidney failure~<15~(or dialysis)~585.5~585.6 (if ESRD)~V
17   II,     5.  7.  1|           6 (if ESRD)~V codes for dialysis or transplantation~5 D if
18   II,     5.  7.  1|         or transplantation~5 D if dialysis (HD or PD)~ ~*Glomerular
19   II,     5.  7.  2|      Renal Association - European Dialysis and Transplant Association (
20   II,     5.  7.  3|           GFR at the beginning of dialysis were similar, hypertension
21   II,     5.  7.  3|          mortality in patients on dialysis is almost five times as
22   II,     5.  7.  3|     compared to patients starting dialysis in the cohort 1980-1984,
23   II,     5.  7.  3|          in the cohort 1980-1984, dialysis patients in the more recent
24   II,     5.  7.  5|           Since April 2007 German dialysis centres, by law, have regularly
25   II,     5.  7.  5|           planned that after 2008 dialysis centres will face disadvantages (
26   II,     5.  7.  5|         is a vital element of the dialysis care system. The government
27   II,     5.  7.  5|     auditing and certification of dialysis providers. Nearly 90% of
28   II,     5.  7.  5|      providers. Nearly 90% of the dialysis centers have a quality certificate.
29   II,     5.  7.  5|    quality of life, especially in dialysis patients. Since 2005, it
30   II,     5.  7.  5|   including secondary prevention, dialysis and kidney transplant.~·
31   II,     5.  7.  5|           years. Accessibility of dialysis therapy is possible in 92
32   II,     5.  7.  5|         therapy is possible in 92 dialysis centres; in 2006, there
33   II,     5.  7.  5|          there were 464 pmp under dialysis treatment. The registry
34   II,     5.  7.  5|           Statistical Yearbook of Dialysis Treatments) is organized
35   II,     5.  7.  5|           in cooperation with the Dialysis Centres.~· There are no
36   II,     5.  7.  6|            In most Member States, dialysis multinational companies
37   II,     5.  7.  6| transplant recipients compared to dialysis patients, whereas costs
38   II,     5.  7.  7|     Lysaght MJ (2002) Maintenance dialysis population dynamics: current
39   II,     9.  3.  1|    measured using the equilibrium dialysis method; in this case the
40  Key,   Ap5.  0.  0|     diabetics~diagnoses~diagnosis~dialysis~diarrhoea~diet~dieticians~